Research interests:


Address: Division of Molecular Medicine
Centenary Campus
Bose Institute
P-1/12 C.I.T. Scheme VII-M
Kolkata - 700054, India
E-Mail: mahadeb[at]
Phone: +91-33-25693256



1. Safina A, Cheney P, Pal M, Brodsky L, Ivanov A, Kirsanov K, Lesovaya E, Naberezhnov D, Nesher E, Koman I, Wang D, Wang J, Yakubovskaya M, Winkler D, Gurova K (2017) FACT is a sensor of DNA torsional stress in eukaryotic cells, Nucleic Acid Research, Jan 12, 2017


2. Hazra, J., Mukherjee, P., Ali, A., and Pal, M. (2017) Engagement of Components of DNA-Break Repair Complex and NFκB in Hsp70A1A Transcription Upregulation by Heat Shock. PLOS ONE Jan 18;12(1):e0168165


3.Nelson, VK., Ali, A., Dutta., N., Ghosh, S., Jana, M., Ganguli, A., Komaro, A., Paul, S., Dwivedi, V., Chatterjee, S.,Jana, N., Lakhotia, SC., Chakrabarti, GC., Misra, AK., Mandal, SC., Pal, M. (2016) Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1, Oncotarget, vol 7, no 48, p 78281


4.Ghosh, N., Ali, A., Das, S., Mandal, S.C., and Pal, M. (2016) Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine. Curr Pharm Des. 22(2): 247-64


5. Dhar G, Chakravarty D, Hazra J, Dhar J, Poddar A, Pal M, Chakrabarti P, Surolia A, Bhattacharyya B (2015) Actin-curcumin interaction: insights into the mechanism of actin polymerization inhibition.

Biochemistry 54:1132-43.  



6. Pal S., Bhattacharjee B., Mandal N C, Mandal S C. and Pal M. (2014) Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 antagonism. J Inflamm (Lond). 2014 Aug 9;11:23.


7. Leonova KI, Brodsky L, Lipchick B, Pal M, Novototskaya L, Chenchik AA, Sen GC, Komarova EA, Gudkov AV (2013) p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natle Acad Sci (USA), 2013 2;110-89-98.


8. Gasparian AV, Burkhart CA, Purmal AA, Brodsky L, Pal M, Saranadasa M, Bosykh DA, Commane M, Guryanova OA, Pal S, Safina A, Sviridov S, Koman IE, Veith J, Komar AA, Gudkov AV, and Gurova KV 2011. Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT. Sci Transl Med. 3, 95ra74.


9. Újvári A, Pal M, and Donal L (2011) The functions of TFIIF during initiation and transcript elongation are differentially affected by phosphorylation by casein kinase 2. J Biol Chem 286, 23160-7.


10. Čabart P,  Újvári A, Pal M and Luse D. (2011) TFIIF is not required for initiation by RNA polymerase II but it is essential to stabilize TFIIB in early transcription complexes, Proc  Natle  Acad Sci (USA), Sep 20;108(38):15786-91.


11. Pal M, Ponticelli A S,  and Luse D (2005)The role of the transcription bubble and TFIIB in promoter clearance by RNA polymerase II. Molecular Cell, 19, 101-110. 

View More




    Image Name Designation Department Campus Contact number Email
    profile image Anirban Manna JRF Division of Molecular Medicine Centenary 25693286
    profile image Asif Ali SRF Division of Molecular Medicine Centenary 25693321
    profile image Chirantan Majumder JRF Division of Molecular Medicine Centenary 25693286
    profile image Joyita Hazra SRF Division of Molecular Medicine Centenary 0
    profile image Payel Das JRF Division of Molecular Medicine Centenary
    profile image Samhita De JRF Division of Molecular Medicine Centenary 25693286
    profile image Suvranil Ghosh SRF Division of Molecular Medicine Centenary 25693243


    Group News: